Latest Financial Health News

SomnoMed Limited reported a solid cash flow performance for Q4 2024, with operating activities generating a net inflow of $1.525 million and ending the quarter with $18.5 million in cash reserves.

SomnoMed reports a robust 19.8% revenue increase in Q2 FY25 and updates its full-year guidance, reflecting strong demand and operational improvements amid ongoing production enhancements.

SportsHero Limited has arranged a $1 million unsecured loan facility to support its working capital needs, with flexible monthly drawdowns and a fixed 10% interest rate. The company has already drawn $100,000 from this facility, signaling ongoing liquidity management efforts.

Regional Express Holdings has completed the transfer of debt from PAGAC Regulus Holding to the Commonwealth of Australia, marking a key step in its ongoing administration process.

Australian Rare Earths Limited has secured a $5 million government grant to advance its Koppamurra Rare Earths Project, while initial drilling at its Overland Uranium Project validates promising geological models for uranium deposits.

Gryphon Capital Income Trust has announced an estimated ordinary dividend of AUD 0.0141 per unit for January 2025, payable in February. The distribution is unfranked and reflects the trust's ongoing income strategy.

Imricor Medical Systems reports strong Q4 CY24 progress with successful FDA review, CE Mark submissions, and an 840% jump in consumables revenue, positioning the company for expanded global market penetration.

Mandrake Resources has announced a significant maiden Inferred Resource of 3.3 million tonnes of Lithium Carbonate Equivalent at its Utah Lithium Project, alongside securing a US$1 million grant from the US Department of Energy to support further exploration and development.

Etherstack has landed its eighth contract deploying digital radio technology for the world's largest iron ore producer in Western Australia, reinforcing its foothold in a critical mining communications sector.

Chrysos Corporation reports a robust Q2 FY25 with a 12% quarter-on-quarter and 53% year-on-year revenue increase, driven by expanding international sales and rising sample volumes. The company secured two new contracts, boosting its PhotonAssay™ footprint and maintaining strong financial health.

Paladin Energy Ltd reported a robust quarterly cash flow for Q4 2024, with a net operating cash inflow of $43.3 million and a strong cash position of $117.1 million, underpinning its ongoing projects and financial flexibility.

Wildcat Resources has delivered a landmark Mineral Resource Estimate for its Tabba Tabba Lithium Project, positioning it as a major player in Australia’s lithium sector with a high-confidence 74.1Mt resource at 1.0% Li2O.